| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
• Magenta Therapeutics, Inc. (NASDAQ:MGTA) stock increased by 13.55% to $9.05 during Monday's pre-market session. The most recent rating by Goldman Sachs, on Jun 8, is at Buy, with a price target of $15.
• Acasti Pharma, Inc. (NASDAQ:ACST) shares increased by 12.50% to $0.60. The most recent rating by Aegis Capital, on May 6, is at Buy, with a price target of $2.
• Mesoblast, Inc. (NASDAQ:MESO) stock increased by 12.12% to $13.50. The most recent rating by HC Wainwright & Co., on May 28, is at Buy, with a price target of $21.
• resTORbio, Inc. (NASDAQ:TORC) shares rose 10.82% to $2.56. The most recent rating by Evercore ISI Group, on Apr 30, is at Outperform, with a price target of $4.
• Cellectar Biosciences, Inc. (NASDAQ:CLRB) stock increased by 10.63% to $1.56. The most recent rating by Oppenheimer, on Jul 1, is at Outperform, with a price target of $5.
• Lianluo Smart, Inc. (NASDAQ:LLIT) shares rose 10.01% to $0.71.
• Centogene, Inc. (NASDAQ:CNTG) stock moved upwards by 9.38% to $26.80. The most recent rating by Baird, on Apr 24, is at Outperform, with a price target of $20.
• BioCardia, Inc. (NASDAQ:BCDA) shares increased by 8.51% to $2.55.
• So-Young Intl, Inc. (NASDAQ:SY) stock increased by 8.40% to $16. The most recent rating by Canaccord Genuity, on May 19, is at Buy, with a price target of $15.
• Evofem Biosciences, Inc. (NASDAQ:EVFM) stock increased by 7.38% to $3.20. The most recent rating by HC Wainwright & Co., on Jun 9, is at Buy, with a price target of $9.
• Endologix, Inc. (NASDAQ:ELGX) shares decreased by 47.63% to $0.40 during Monday's pre-market session. According to the most recent rating by BTIG, on May 12, the current rating is at Neutral.
• Alterity Therapeutics, Inc. (NASDAQ:ATHE) stock declined 8.76% to $1.46.
• Myos Rens Technology, Inc. (NASDAQ:MYOS) stock declined 5.89% to $1.60.
• Celsion, Inc. (NASDAQ:CLSN) stock decreased by 4.93% to $4.05.
• Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) shares fell 4.92% to $1.16.
• Cocrystal Pharma, Inc. (NASDAQ:COCP) stock fell 4.58% to $1.46. The most recent rating by Noble Capital Markets, on Jun 16, is at Outperform, with a price target of $5.
• 9 Meters Biopharma, Inc. (NASDAQ:NMTR) shares declined 4.35% to $0.61.
• Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) shares declined 3.11% to $0.29.
Posted In: ACST ATHE BCDA CLRB CLSN CNTG COCP CTXR ELGX EVFM LLIT MESO MGTA MYOS NMTR SY TORC TTNP
